Yaba is a small pressed tablet containing methamphetamine and caffeine. It is the dominant form of methamphetamine in Thailand, Myanmar, Laos, Cambodia and increasingly Bangladesh, and a different object from the crystalline methamphetamine that dominates coverage in Australia, New Zealand and North America, though the active drug is the same molecule.
This page sets out what the forensic and epidemiological sources say, and where they disagree. Some figures those sources publish are deliberately withheld here, and we say so each time.
What is actually in a yaba tablet
Methamphetamine, caffeine, a binder, a colouring and often a flavouring.
The proportions are the part worth understanding. UNODC’s 2026 regional assessment reports that methamphetamine tablets across East and South East Asia typically contain a minority share of methamphetamine by weight, with caffeine present at a higher level. The tablet is mostly not the drug people think they are taking. We are not reproducing the percentages, because this page should not work as a potency reference.
Two further findings in the same report matter more than the averages. Tablets seized in a Thai province bordering Myanmar tested above the national average for methamphetamine content, and within that province, tablets of one colour and tablets of another, carrying the same stamped branding, tested at different strengths. Our reading is the practical consequence: colour, stamp and appearance carry no reliable information about a given tablet.
The flavouring is documented rather than folkloric. A 2002 forensic analysis of tablets seized in Thailand, in Forensic Science International, identified caffeine and ethyl vanillin, the compound behind a vanilla smell and taste, among the diluents and adulterants present. It also found opioid compounds, including acetylcodeine and diacetylmorphine, in many samples. That study is more than two decades old, current UNODC profiling does not report the same opioid contamination, and we cannot say it describes today’s tablets. It is here because a tablet from an unregulated supply has no guaranteed contents, and the age of the paper does not weaken that.
The caffeine is not filler, and the human evidence on it is thin
The obvious assumption is that caffeine is a cheap bulking agent, and UNODC does describe it as one. The laboratory evidence suggests it is not only that.
Two Thai research groups have tested the specific combination rather than methamphetamine alone. A 2011 study in Neuroscience Letters, framed explicitly around Ya-Ba, found that methamphetamine and caffeine together, at concentrations that were individually non-toxic, reduced the survival of human neuroblastoma cells, and that the combination raised mortality in rats alongside markers of oxidative stress in the striatum. A 2015 follow-up in Neurotoxicity Research reported a similar potentiating effect and proposed a mechanism involving inhibition of autophagy.
Here is the inconvenient half. Both are laboratory studies, in cell lines and rodents, and neither tells you what happens in a person. We searched for human trials or cohort data on the combination as consumed in tablet form and found none. That absence is the finding: the claim that yaba is more dangerous than methamphetamine alone because of the caffeine rests on preclinical work and, as far as we could establish, not yet on human evidence. Our observation is that this is an open question, not a settled one.
Swallowed, crushed, smoked
A tablet looks like something you swallow, and the route matters more than the format suggests. UNODC has described yaba as commonly crushed and smoked rather than taken orally.
The European Union Drugs Agency states the principle plainly: drugs that can be smoked, methamphetamine among them, “are much more addictive and more likely to cause problems when consumed in this way than when taken orally”. Clinical data point the same way. A study of 974 people in outpatient methamphetamine treatment in the United States found those who smoked the drug almost as severely impaired on many treatment response measures as those who injected it, with intranasal use least impaired. That sample was American and predates the current market, so it transfers with caution.
Our reading is that this is the most under stated thing about yaba. A pressed, flavoured, brightly coloured tablet reads as a milder proposition than a pipe. Crushed and smoked, it is not one.
Why the north of Thailand sits inside this market
UNODC’s 2026 report records nearly 1.9 billion methamphetamine tablets seized across East and South East Asia in 2025, of which Thailand alone seized almost 1.2 billion, around 62 per cent of the regional total. Myanmar remains the principal source, and UNODC describes tablet finishing and packaging operations sited close to the Thai border in Shan State.
Of the crystalline methamphetamine seized in Thailand in 2025, the largest provincial shares were in the northern border provinces of Chiang Rai and Chiang Mai, alongside Bangkok. Thailand also records the lowest wholesale methamphetamine prices in the region, which UNODC attributes to proximity to production. We are not printing those price figures.
One caution, from UNODC itself: the long rise in seizures “highly likely reflects a combination of expanded supply and an improved law enforcement response”. A seizure figure measures interdiction as well as availability, and the number alone cannot separate them.
Who is using it, and what the treatment figures show
Thailand’s methamphetamine related treatment admissions rose from 177,533 people in 2024 to 231,669 in 2025, roughly 90 per cent of all drug treatment admissions nationally. The split inside that number is the point of this page: 224,741 were linked to methamphetamine tablets and 6,928 to crystalline methamphetamine. In Thailand, treatment demand is a tablet problem.
The ASEAN Narcotics Cooperation Center, hosted by Thailand’s Office of the Narcotics Control Board, describes yaba as remaining “dominant in rural and low-income populations”. This is a description of reported patterns of drug use, not an indication that drug use is confined to, or characteristic of, people in those communities. UNODC’s older material describes traditional use by occupational workers such as long distance drivers, and ethnographic research in Chiang Mai, published in the International Journal on Drug Policy, traced a shift from a labourers’ drug to a youth drug taken for pleasure and performance. Current regional reporting does not break use down by occupation or migration status, so the labour and migrant picture rests on older, largely qualitative work.
A number that cuts the other way: Thailand’s national household surveys recorded past year yaba use at well under one per cent of adults. Such surveys under reach the people most affected, but our observation is that the enormous seizure totals and the small survey prevalence describe the same country, and any account quoting only one of them is incomplete.
It is tempting to rank the two forms, and the sources do not agree. The same ASEAN analysis states that crystalline methamphetamine “presents a more acute public health threat due to its higher purity and greater addictive potential” than tablets. That cuts against the premise of a page about yaba and it belongs here. The counterweight is that the tablet is what most people in Thailand are in treatment for, and that a crushed and smoked tablet is not taken at the strength a purity table implies. We have written separately about crystal methamphetamine, or ice, where the market and the route are different.
Psychosis, the crash, and the medicine that does not exist
Methamphetamine in any form can produce psychotic symptoms, and they can occur when a person is not actively using. A cross country study of inpatients with methamphetamine psychosis, drawing on data from Thailand, Australia, Japan and the Philippines, found persecutory delusions to be the most common lifetime symptom and auditory hallucinations the most common current one.
UNODC describes a crash after the effects wear off, with prolonged sleep and low mood. No medication reliably shortens it: a 2023 systematic review and meta-analysis of medicines for methamphetamine withdrawal found insufficient evidence that any is effective, with generally low to very low certainty evidence.
The same gap exists for the disorder itself. The US National Institute on Drug Abuse states that “there is no FDA-approved medication for methamphetamine use disorder or any other stimulant use disorder”, and names contingency management as the best studied behavioural treatment, alongside cognitive behavioural therapy and motivational interviewing. Our reading is that this is the most important thing for anyone comparing options to understand. Stimulant treatment is psychological and structural work rather than a prescription, and a programme implying otherwise is overselling.
If someone has a very high temperature, is confused, is having chest pain, is seizing or is losing consciousness, that is an emergency. Call your local emergency number.
Thailand’s law has moved twice, in opposite directions
This section states law rather than medicine. Check it against current Thai legal advice.
Thailand’s Narcotics Code, promulgated in 2021, consolidated earlier laws and created a separate, more lightly punished offence of possession for consumption. A quantity set in a Ministry of Public Health ministerial regulation determines whether that presumption applies. In 2024 that quantity was reduced sharply, narrowing the route into treatment rather than prosecution. We are not printing either the old or the new figure.
Two things follow that are easy to miss. First, the presumption is not absolute: legal analysis in Thai Legal Studies in 2024 notes that a court can still convict of ordinary possession where the amount falls below the regulated quantity. Nobody should read a threshold as a safe allowance. Second, the International Drug Policy Consortium reports drug cases before Thai courts of first instance rising by roughly a quarter between 2023 and 2024, reversing three years of falling drug related incarceration. Thai drug policy has changed direction more than once in five years and may change again.
Talking to someone about yaba
The Orchid Recovery is a residential addiction and mental health treatment centre in Hang Dong District, Chiang Mai, in the Thai province that sits on the corridor this drug arrives through.
If methamphetamine use has stopped being controllable, our pages on methamphetamine addiction treatment, medically supervised drug detox and what residential treatment involves set out what that looks like, our clinical team is listed here, and you can speak to us. Stimulant relapse risk is long tailed, which is why aftercare matters here. If the concern is an acute reaction, the signs of methamphetamine overdose is the more useful page.
Sources
- UNODC, Synthetic Drugs in East and Southeast Asia: Latest developments and challenges 2026
- UNODC, Asia’s synthetic drug market breaks records, 12 June 2026
- UNODC, Rise in production and trafficking of synthetic drugs from the Golden Triangle, 28 May 2025
- UNODC, Yaba, the ‘crazy medicine’ of East Asia, 2008
- ASEAN Narcotics Cooperation Center, ASEAN Drug Monitoring Report 2024 (hosted by Thailand’s ONCB)
- Sinchai et al, Caffeine potentiates methamphetamine-induced toxicity both in vitro and in vivo, Neuroscience Letters, 2011
- Pitaksalee et al, Autophagy inhibition by caffeine increases toxicity of methamphetamine in SH-SY5Y neuroblastoma cell line, Neurotoxicity Research, 2015
- Puthaviriyakorn et al, Identification of impurities and statistical classification of methamphetamine tablets (Ya-Ba) seized in Thailand, Forensic Science International, 2002
- European Union Drugs Agency, Methamphetamine drug profile
- Brecht et al, Methamphetamine dependence: a closer look at treatment response and clinical characteristics associated with route of administration in outpatient treatment, The American Journal on Addictions, 2007
- Cohen, Crazy for Ya Ba: methamphetamine use among northern Thai youth, International Journal on Drug Policy, 2014
- Angkurawaranon et al, Trends in the use of illicit substances in Thailand: results from national household surveys, Drug and Alcohol Review, 2018
- Srisurapanont et al, Psychotic symptoms in methamphetamine psychotic in-patients, International Journal of Neuropsychopharmacology, 2003
- Systematic review and meta-analysis of pharmacotherapy for methamphetamine withdrawal, 2023, PubMed record 35862266
- National Institute on Drug Abuse, Methamphetamine
- Thai Legal Studies, The Constitutionality of “Possession” and “Possession for Consumption”, 2024
- International Drug Policy Consortium, Thailand meets new drug policy challenges in light of the upcoming national election, February 2026
Frequently Asked Questions
What is the yaba drug?
Yaba is a small pressed tablet containing methamphetamine and caffeine, along with a binder, colouring and often a flavouring. It is the dominant form of methamphetamine in Thailand, Myanmar, Laos and Cambodia, and its use has spread towards Bangladesh. The name is Thai and translates roughly as crazy medicine. The active drug is the same methamphetamine found in crystalline form.
Is yaba the same as crystal meth?
Same drug, different product. Yaba is a compressed tablet in which methamphetamine is a minority component and caffeine makes up more of the mass. Crystalline methamphetamine is close to pure. ASEAN regional analysis describes the crystalline form as the more acute public health threat, while tablets account for the overwhelming majority of methamphetamine treatment admissions in Thailand.
Does the caffeine in yaba make it more dangerous?
The evidence points that way but is not conclusive. Two Thai laboratory studies found that methamphetamine and caffeine together were toxic to cells at concentrations that were harmless individually, and that the combination increased mortality in rats. We found no human trials or cohort studies testing the combination in people, so the question remains open rather than settled.
How can you tell how strong a yaba tablet is?
You cannot, and this is one of the clearest findings in the data. UNODC reports that tablets seized in a single Thai province carrying the same branding differed in methamphetamine content by colour, and that tablets near the Myanmar border tested above the national average. Appearance, stamp and colour carry no reliable information about strength.
What are the withdrawal effects of yaba?
The characteristic pattern is a crash after the stimulant effect fades, with prolonged sleep, low mood and strong cravings, and it can last well beyond the first few days. No medication has been shown to treat it reliably. A 2023 systematic review and meta-analysis of medicines for methamphetamine withdrawal found insufficient evidence that any is effective, with generally low to very low certainty evidence.
Is there a medication that treats yaba addiction?
No. The US National Institute on Drug Abuse states there is no approved medication for methamphetamine use disorder or any other stimulant use disorder. The best studied treatment is contingency management, a structured behavioural approach, with cognitive behavioural therapy and motivational interviewing also used. Medical supervision still matters, particularly where sleep, mood, psychosis or other substances are involved.
Can yaba cause psychosis?
Yes, and it can occur when a person is not currently using. A study of inpatients with methamphetamine psychosis drawing on data from Thailand, Australia, Japan and the Philippines found persecutory delusions to be the most common lifetime symptom, with auditory hallucinations the most common current one. Anyone experiencing this needs urgent assessment by a clinician rather than reassurance from a web page.
Is yaba illegal in Thailand?
Yes. Thailand's 2021 Narcotics Code created a separate, more lightly punished offence of possession for consumption, with a quantity set by ministerial regulation deciding whether that applies. That quantity was reduced sharply in 2024. Legal analysis notes the presumption is not absolute, so a small amount does not guarantee treatment rather than prosecution. Take current Thai legal advice, not this page.
How does someone start treatment for methamphetamine use?
With a conversation. An admissions call with The Orchid Recovery covers what has been used and for how long, physical and mental health, and whether other substances are involved. Our on-site psychiatrist then reviews whether a residential stay is appropriate. Programmes run four, eight or twelve weeks for adults, on a residential basis only. Admission depends on that review rather than on the enquiry.